ArticleCancer gene therapy2025

Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/C.

Franziska Maria Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.